University Medical Centre Groningen, Groningen (Netherlands (The))
55
presentations
10
followers
4
more
presentations
in this session
Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR
Major bleeding among patients with atrial fibrillation treated with rivaroxaban or warfarin in Sweden. Interim results from an on-going post-authorization study
Speaker:
Associate Professor L. Friberg (Stockholm, SE)